American Portfolios Advisors Anavex Life Sciences Corp. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, American Portfolios Advisors holds 6,100 shares of AVXL stock, worth $55,693. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,100Holding current value
$55,693% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding AVXL
# of Institutions
155Shares Held
27.3MCall Options Held
515KPut Options Held
838K-
Black Rock Inc. New York, NY6.39MShares$58.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$43.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$28 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$17.2 Million0.0% of portfolio
-
Wealthgarden F.S. LLC El Segundo, CA910KShares$8.31 Million0.32% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $712M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...